Bank of Montreal’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-19,095
| Closed | -$98K | – | 5166 |
|
|
2019
Q2 | $98K | Sell |
19,095
-26,951
| -59% | -$121K | ﹤0.01% | 3351 |
|
|
2019
Q1 | $166K | Sell |
46,046
-5,655
| -11% | -$24.5K | ﹤0.01% | 2809 |
|
|
2018
Q4 | $317K | Buy |
51,701
+341
| +0.7% | +$2.08K | ﹤0.01% | 2371 |
|
|
2018
Q3 | $301K | Buy |
51,360
+31,053
| +153% | +$155K | ﹤0.01% | 2555 |
|
|
2018
Q2 | $86K | Buy |
20,307
+5,317
| +35% | +$26.8K | ﹤0.01% | 3202 |
|
|
2018
Q1 | $66K | Sell |
14,990
-182
| -1% | -$812 | ﹤0.01% | 3130 |
|
|
2017
Q4 | $80K | Hold |
15,172
| – | – | ﹤0.01% | 3095 |
|
|
2017
Q3 | $93K | Hold |
15,172
| – | – | ﹤0.01% | 3016 |
|
|
2017
Q2 | $109K | Hold |
15,172
| – | – | ﹤0.01% | 2956 |
|
|
2017
Q1 | $80K | Buy |
15,172
+182
| +1% | +$1.23K | ﹤0.01% | 2914 |
|
|
2016
Q4 | $107K | Sell |
14,990
-16,453
| -52% | -$133K | ﹤0.01% | 2804 |
|
|
2016
Q3 | $294K | Buy |
31,443
+16,453
| +110% | +$137K | ﹤0.01% | 2295 |
|
|
2016
Q2 | $95K | Hold |
14,990
| – | – | ﹤0.01% | 2828 |
|
|
2016
Q1 | $83K | Sell |
14,990
-483
| -3% | -$1.82K | ﹤0.01% | 2873 |
|
|
2015
Q4 | $87K | Buy |
15,473
+483
| +3% | +$3.19K | ﹤0.01% | 2832 |
|
|
2015
Q3 | $127K | Sell |
14,990
-14,000
| -48% | -$237K | ﹤0.01% | 2494 |
|
|
2015
Q2 | $438K | Hold |
28,990
| – | – | ﹤0.01% | 2038 |
|
|
2015
Q1 | $464K | Hold |
28,990
| – | – | ﹤0.01% | 1972 |
|
|
2014
Q4 | $517K | Hold |
28,990
| – | – | ﹤0.01% | 2043 |
|
|
2014
Q3 | $291K | Sell |
28,990
-200
| -0.7% | -$2.42K | ﹤0.01% | 2351 |
|
|
2014
Q2 | $456K | Buy |
29,190
+200
| +0.7% | +$2.83K | ﹤0.01% | 2136 |
|
|
2014
Q1 | $538K | Buy |
+28,990
| New | +$581K | ﹤0.01% | 2017 |
|
Other funds holding PETX
Bank of Montreal's PETX Position: Q3 2019 in Review
Bank of Montreal sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 19,095 shares — an estimated $98K sold.
Bank of Montreal first reported a position in PETX in Q1 2014 and held it in 22 quarters. The position peaked at $538K in Q1 2014. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- Bank of Montreal reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Bank of Montreal sold 19,095 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $98K.
- Bank of Montreal first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and held it in 22 quarters.
- Bank of Montreal's Aratana Therapeutics, Inc. position peaked at $538K in Q1 2014.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on Bank of Montreal's 13F filing for Q3 2019, filed 8 Nov 2019.